Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-03-28

FDA Approved: AMBRISENTAN — Original Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved the original application for ambrisentan (generic) submitted by Actavis Pharma, enabling the generic version to be marketed. This represents an app…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ambrisentan (Ambrisentan)

Snippet

ORIG AP for AMBRISENTAN (AMBRISENTAN)